BETAMETHASONE DIPROPIONATE | A077111 | FOUGERA PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Teligent Pharma Inc FDA-2017-P-5947 · 5 docket documents Teligent Pharma, Inc. filed this petition pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate either ANDA 077111 (Betamethasone Dipropionate Lotion USP 0.05% Augmented held by Fougera Pharmaceuticals, Inc.) or ANDA 077477 (held by Taro Pharmaceuti | 505(q) | 2017-09-27 | Withdrawn | Teligent Pharma Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.5526
per ml
Lowest NADAC/Unit
$0.5382
per ml
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00168026730BETAMETHASONE DP AUG 0.05% LOT | $0.5526 | ML | Generic | — | 2026-06-17 |
| 00168026760BETAMETHASONE DP AUG 0.05% LOT | $0.5382 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.